Tricyclic compounds, processes for their preparation, compositions containing such compounds and their use in medicine
申请人:THE WELLCOME FOUNDATION LIMITED
公开号:EP0150891A1
公开(公告)日:1985-08-07
Compounds of formula (I)
wherein n is 0, 1 or 2; one of R1 and R2 is hydrogen and the other is selected from carbamoyl, N-C1-4 alkylcarbamoyl, N,N-di-C1-4 alkylcarbamoyl, carbamimidoyl, N1-C1-4 alkylcarbamimidoyl, N2-C1-4 alkylcarbamimidoyl, N1-C1-4 alkyl-N2-C1-4 alkylcarbamimidoyl, N1,N1-di-C1-4 alkylcarbamimidoyl, N1,N1-di-C1-4alkyl-N2-C1-4 alkvlcarbamimidoyl, tetrazol-5-yl (optionally substituted by one or more C1-4 alky' groups) and imidaxolin-2-yl optionally substituted by one or more C1-4 alkyl groups); and R3 is selected from hydrogen, saturated and unsaturated aliphatic hydrocarbon moieties containing from 1 to 4 carbon atoms, groups OR4 (where R4 is selected from hydrogen and saturated and unsaturated aliphatic hydrocarbon moieties containing from 1 to 4 carbon atoms), halo, groups of formula -NR5R6 (where R5 and R6 are independently selected from hydrogen, C1-4 alkyl and hydroxy C1-4 alkyl, provided that the total number of carbon atoms in R5 and R6 does not exceed 4), amino C1-4 alkylamino and morpholino, provided that when R1 is carbamoyl and R2 and R3 are both hydrogen, then n is 0 or 1; and physiologically acceptable salts thereof, and their pro-drugs and metabolites are inhibitors of monoamine oxidase-A and are useful in the prophylaxis and treatment of mental disorders such as depression.
式(I)化合物
其中 n 为 0、1 或 2;R1 和 R2 中的一个为氢,另一个选自氨基甲酰基、N-C1-4 烷基氨基甲酰基、N,N-二-C1-4 烷基氨基甲酰基、氨基亚氨酰基、N1-C1-4 烷基氨基亚氨酰基、N2-C1-4 烷基氨基亚氨酰基、N1-C1-4 烷基-N2-C1-4 烷基氨基亚氨酰基、N1,N1-二-C1-4烷基氨基甲酰亚胺、N1,N1-二-C1-4烷基-N2-C1-4烷基氨基甲酰亚胺、四唑-5-基(可选择被一个或多个 C1-4 烷基取代)和咪唑啉-2-基(可选择被一个或多个 C1-4 烷基取代);和 R3 选自氢、含 1 至 4 个碳原子的饱和及不饱和脂肪族烃基、OR4 基团(其中 R4 选自氢、含 1 至 4 个碳原子的饱和及不饱和脂肪族烃基)、卤素、式-NR5R6(其中 R5 和 R6 独立选自氢、C1-4 烷基和羟基 C1-4 烷基,条件是 R5 和 R6 中的碳原子总数不超过 4)、氨基 C1-4 烷基氨基和吗啉基,条件是当 R1 为氨基甲酰基且 R2 和 R3 均为氢时,则 n 为 0 或 1;及其生理上可接受的盐类,它们的原药和代谢物是单胺氧化酶-A 的抑制剂,可用于预防和治疗抑郁症等精神疾病。